Preston Klassen is CEO & President at Metacrine, Inc. (MTCR). They have made 6 open-market trades across 3 companies since 2013, most recently 2025-06-25.
CIK 0001493056
2 open-market purchases totalling $245K since 2021, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RGLS | BUY | 2025-06-03 | 2025-06-04 | $7.99 | $96K | +2.8% | N/A | N/A |
| RGLS | SELL · 10b5-1 | 2025-01-13 | 2025-01-15 | $1.26 | $40K | -8.6% | -5.5% | +52.3% |
| MTCR | SELL | 2023-01-26 | 2023-01-27 | $0.41 | $312K | +3.1% | -6.7% | -6.7% |
| MTCR | SELL | 2022-04-19 | 2022-04-20 | $0.50 | $22K | -9.9% | -14.6% | +5.0% |
| MTCR | BUY | 2021-05-20 | 2021-05-20 | $3.64 | $150K | +1.3% | +7.1% | -28.5% |
| ARNA | SELL | 2019-01-07 | 2019-01-08 | $42.06 | $816K | +0.1% | +8.5% | +13.9% |
| ARNA | SELL | 2019-01-07 | 2019-01-08 | $41.68 | $650K | +0.1% | +8.5% | +13.9% |
| OREX | SELL · 10b5-1 | 2013-07-25 | 2013-07-29 | $7.16 | $510K | N/A | N/A | N/A |
| OREX | SELL · 10b5-1 | 2013-05-28 | 2013-05-30 | $7.21 | $207K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.